Archives
September 28-29
Target Identification and Validation – Part 1
RNA as a Drug Target
PROTACs and Targeted Protein Degradation – Part 1
Antibodies Against Membrane Protein Targets – Part 1
GPCR-Based Drug Discovery
3D Cellular Models
Immunology and Oncology: Emerging Drug Targets
September 29-30
Target Identification and Validation – Part 2
Lead Generation Strategies
PROTACs and Targeted Protein Degradation – Part 2
Antibodies Against Membrane Protein Targets – Part 2
Small G Proteins
NASH and Fibrosis
Preclinical Strategies and Models in Oncology